It's Time To Cure The FDA's Regulatory Sclerosis The FDA has not displayed sufficient urgency throughout the COVID-19 crisis—and is threatening to repeat its mistakes with the ongoing outbreak of monkeypox. It's long past time for lawmakers to reform the sclerotic agency.